-
1
Pharmacogenetics of Oral Antidiabetic Drugs
Published 2013-01-01“…Only in the last five years, intensive research has been conducted in the pharmacogenetics of these drugs based mainly on the retrospective register studies, but only a handful of associations detected in these studies were replicated. …”
Get full text
Article -
2
-
3
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
Published 2016-01-01“…Although not higher than in the general pediatric population, a high frequency of patients was overweight/obese, with abnormalities in metabolic parameters and some pharmacogenetic associations.…”
Get full text
Article -
4
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals
Published 2016-01-01“…Other factors are related to pharmacokinetics and pharmacogenetics of the specific ARV agent or mediated by drug interactions, local inflammation, and blood flow. …”
Get full text
Article -
5
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
Published 2017-01-01“…The advantage of pharmacometabolomics is that it does not only predict the response but also provide extensive information on the metabolic pathways implicated with the response. Integrating pharmacogenetics with pharmacometabolomics can give insight on unknown genetic and nongenetic factors associated with the response. …”
Get full text
Article -
6
Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers
Published 2024-12-01Subjects: Get full text
Article -
7
-
8
Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
Published 2015-12-01Subjects: “…pharmacogenetic markers…”
Get full text
Article -
9
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
Published 2023-06-01Subjects: Get full text
Article -
10
Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria
Published 2022-01-01“…The parasite genetic factors involve undergoing mutation in the drug target sites or increasing the drug target gene copy number to prevent the intended action of the antimalarial drugs. The host pharmacogenetic factors which determine how a particular antimalarial drug is metabolized could result in variations of drug plasma concentration and consequently contribute to variable treatment outcomes and the emergence or propagation of resistant parasites. …”
Get full text
Article -
11
Pharmacogenetics: Influence of CYP2C9*2 and *3 alleles polymorphisms on Iraqi type 2 diabetic patients
Published 2024-01-01Subjects: Get full text
Article -
12
The Frequency of <i>DPYD</i> c.557A>G in the Dominican Population and Its Association with African Ancestry
Published 2024-12-01Subjects: Get full text
Article -
13
GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study
Published 2025-02-01Subjects: Get full text
Article -
14
MORE ATTENTION TO QUALITY OF PHARMACOTHERAPY IN PSYCHIATRY
Published 2024-11-01Subjects: Get full text
Article -
15
Impact of donor CYP3A5 genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients
Published 2024-04-01Subjects: Get full text
Article -
16
-
17
Treatment and Genotypic Characteristics of Patients with Rheumatoid Arthritis
Published 2025-01-01Subjects: Get full text
Article -
18
Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial
Published 2024-11-01“…Introduction Genetic variations impact drug response, driving the need for personalised medicine through pre-emptive pharmacogenetic testing. However, the adoption of pre-emptive pharmacogenetic testing for commonly prescribed drugs, such as statins, outside of tertiary hospitals is limited due to a lack of pharmacoeconomic evidence to support widespread implementation by healthcare policy-makers. …”
Get full text
Article -
19
How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWH
Published 2025-01-01“…ROS influence the expression of gene-encoding enzymes and transporters involved in drug biotransformation. In addition, pharmacogenetics can influence transporter activity, and thus drug exposure. …”
Get full text
Article -
20
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
Published 2025-02-01Get full text
Article